Clin2
NCT06760455Worth exploringRecruiting

Safety of BPR-30221616 Injection in Healthy People

Healthy Participants

This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
48 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are generally healthy and have no major medical conditions.
  • You are not pregnant or breastfeeding and agree to use effective birth control for 12 months after the injection.
  • You have not taken prescription or over-the-counter medications in the last few weeks.
  • You are not a heavy smoker (no more than 5 cigarettes per day).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07432698Not yet recruiting· Phase 1
Testing AK0406 injection safety in healthy volunteers

This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.

Bayswater, Victoria
NCT07190716Not yet recruiting· Phase 1
Safety study of GR2301 injection in healthy volunteers

This trial tests a new injection called GR2301 to see if it is safe in healthy people. Volunteers will help researchers understand any side effects before the drug is given to patients with a disease.

Beijing, Beijing Municipality
NCT06842537Recruiting· Phase 1
Safety study of SYH2062 injection in healthy volunteers

This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.

Beijing, Beijing Municipality
NCT07647224Not yet recruiting· Phase 1
Testing a new injection in healthy adults in China

This is an early-stage study testing a new medicine called GR2301 given as multiple injections. Researchers want to see how safe it is and how the body handles it in healthy volunteers with no serious medical conditions.

Beijing, Beijing Municipality
NCT06561542Recruiting· Phase 1
Safety study of LX22001 injection in healthy adults

This study tests a new injection called LX22001 in healthy volunteers to see how it is processed in the body and if it is safe. It is a first-in-human trial, so you must be in good health and meet specific age, weight, and lifestyle requirements.

Beijing, Beijing Municipality
NCT06917482Recruiting· Phase 1
Testing a new drug called BW-40202 in healthy people

This study tests a new medicine called BW-40202 for the first time in people. It is for healthy volunteers to see if the drug is safe and how it works in the body. You must be in good general health to take part.

Brisbane, Queensland

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.